Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era

Cancer

Volumn 121, Issue 15, 2015, Pages 2594-2602

  Keane, Florence K ^a   Chen, Yui Hui ^b   Neville, Bridget A ^c   Tishler, Roy B ^d   Schoenfeld, Jonathan D ^d   Catalano, Paul J ^b   Margalit, Danielle N ^d  

^a HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^b DANA FARBER HARVARD CANCER CENTER   (United States)

^c ARIADNE LABS   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

American Joint Committee on Cancer (AJCC) cancer staging; carcinoma; head and neck cancer; human papilloma virus; oropharyngeal cancer; squamous cell

Indexed keywords

ADOLESCENT; ADULT; AGED; CANCER REGISTRY; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; COHORT ANALYSIS; COMPLICATION; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; ISOLATION AND PURIFICATION; LYMPH NODE; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PREDICTIVE VALUE; PROGNOSIS; VERY ELDERLY; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEER PROGRAM; YOUNG ADULT;

EID: 84937525222     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29402     Document Type: Article

References (37)

1. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-619.
2. Chaturvedi AK, Engels EA, Pfeiffer RM, et al., Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294-4301.
3. Marur S, D'Souza G, Westra WH, Forastiere AA,. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010; 11: 781-789.
4. Ang KK, Harris J, Wheeler R, et al., Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010; 363: 24-35.
5. Licitra L, Perrone F, Bossi P, et al., High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol. 2006; 24: 5630-5636.
6. Fakhry C, Westra WH, Li S, et al., Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008; 100: 261-269.
7. Ragin CCR, Taioli E,. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer. 2007; 121: 1813-1820.
8. Layland MK, Sessions DG, Lenox J,. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+. Laryngoscope. 2005; 115: 629-639.
9. Mamelle G, Pampurik J, Luboinski B, Lancar R, Lusinchi A, Bosq J,. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg. 1994; 168: 494-498.
10. Hong AM, Martin A, Armstrong BK, et al., Human papillomavirus modifies the prognostic significance of T stage and possibly N stage in tonsillar cancer. Ann Oncol. 2013; 24: 215-219.
11. Spector ME, Gallagher KK, Bellile E, et al., Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma. Head Neck. 2014; 36: 1233-1240.
12. Rich JT, Milov S, Lewis JS, Thorstad WL, Adkins DR, Haughey BH,. Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope. 2009; 119: 1709-1719.
13. Haughey BH, Hinni ML, Salassa JR, et al., Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck. 2011; 33: 1683-1694.
14. Haughey BH, Sinha P,. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Laryngoscope. 2012; 122 (suppl 2): S13-S33.
15. Edge SB, Compton CC,. The American Joint Committee on Cancer: the 7th edition of the AJCC Cancer Staging Manual and the future of TNM. Ann Surg Oncol. 2010; 17: 1471-1474.
16. National Cancer Institute. SEER Data, 1973-2011. http://seer.cancer.gov/data/. Accessed December 15, 2014.
17. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
18. National Cancer Institute. SEER extent of disease-1988: codes and coding instructions. http://seer.cancer.gov/archive/manuals/EOD10Dig.pub.pdf. Accessed December 14, 2014.
19. Collaborative Stage Data Collection System. https://cancerstaging.org/cstage/Pages/default.aspx. Accessed December 14, 2014.
20. Jonckheere AR,. A distribution-free k-sample test against ordered alternatives. Biometrika. 1952: 133-145.
21. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958; 53: 457-481.
22. Cox DR,. Regression models and life tables. J R Stat Soc B. 1972; 34: 187-220.
23. Royston P,. Explained variation for survival models. Stata J. 2006; 6: 83-96.
24. Goldenberg D, Begum S, Westra WH, et al., Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck. 2008; 30: 898-903.
25. Yasui T, Morii E, Yamamoto Y, et al., Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS One. 2014; 9: e95364.
26. O'Sullivan B, Huang SH, Siu LL, et al., Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis. J Clin Oncol. 2013; 31: 543-550.
27. O'Sullivan B, Huang SH, Perez-Ordonez B, et al., Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation. Radiother Oncol. 2012; 103: 49-56.
28. Pfister DG, Spencer S, Brizel DM, et al., Head and neck cancers, version 2. 2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014; 12: 1454-1487.
29. Corry J, Peters LJ, Rischin D,. Optimising the therapeutic ratio in head and neck cancer. Lancet Oncol. 2010; 11: 287-291.
30. ClinicalTrials.gov. Radiation therapy with cisplatin or cetuximab in treating patients with oropharyngeal cancer. https://clinicaltrials.gov/ct2/show/NCT01302834. Accessed December 14, 2014.
31. Cmelak A, Li S, Marur S, et al., Reduced-dose IMRT in human papilloma virus (HPV)-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response (cCR) to induction chemotherapy (IC). ASCO Meet Abstr. 2014; 32: E1308.
32. ClinicalTrials.gov NCT0189849. Transoral surgery followed by low-dose or standard-dose radiation therapy with or without chemotherapy in treating patients with HPV positive stage III-IVA oropharyngeal cancer. https://clinicaltrials.gov/ct2/show/NCT01898494?term=NCT01898494&rank=1. Accessed February 2, 2015.
33. Aizer AA, Chen MH, McCarthy EP, et al., Marital status and survival in patients with cancer. J Clin Oncol. 2013; 31: 3869-3876.
34. Liu GFF, Ranck MC, Solanki AA, et al., Racial parities in outcomes after radiotherapy for head and neck cancer. Cancer. 2014; 120: 244-252.
35. Stein AP, Saha S, Yu M, Kimple RJ, Lambert PF,. Prevalence of human papillomavirus in oropharyngeal squamous cell carcinoma in the United States across time. Chem Res Toxicol. 2014; 27: 462-469.
36. Gillison ML, Zhang Q, Jordan R, et al., Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol. 2012; 30: 2102-2111.
37. Mayne ST, Cartmel B, Kirsh V, Goodwin WJ,. Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx. Cancer Epidemiol Biomarkers Prev. 2009; 18: 3368-3374.